A study evaluating efficacy of treatment of botulinum toxin in patients with chronic migraine as per PREEMPT protocol.

Trial Profile

A study evaluating efficacy of treatment of botulinum toxin in patients with chronic migraine as per PREEMPT protocol.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2017 New trial record
    • 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top